Rubicon Medical Corp.

PositionSalt Lake City - Brief Article

Salt Lake City -- RUBICON MEDICAL CORP., a developer and manufacturer of medical devices, has announced that the major adverse cardiac event (MACE) rate was three percent 30 days following the procedures involving 33 initial patients enrolled in the RULE-SVG study of the Rubicon Filter in...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT